Contribution: Industrial Research Assistance Program – Contributions to Firms
TOPIRX Therapeutics Inc.
$50,000.00
Development of a novel topical finasteride product
FY 2019-20 · 2019-09-01
Summary
The Firm is developing a novel patent protected topical formulation of finasteride for the treatment of male pattern baldness.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
780995130
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-09-01 | 2019-20 | $50,000.00 |
| 1 | 2019-09-01 | 2019-20 | $50,000.00 |
| 2 | 2019-09-01 | 2019-20 | $50,000.00 |
| 3 | 2019-09-01 | 2019-20 | $50,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 182 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 182 jours.
Agreement End Date
2021-03-31
Agreement Number
933410
Agreement Start Date
2019-09-01
Agreement Title
Development of a novel topical finasteride product
Agreement Title (French)
Développement d'un nouveau produit topique à base de finastéride
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Date
2020-09-22
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The Firm is developing a novel patent protected topical formulation of finasteride for the treatment of male pattern baldness.
Description (French)
L'entreprise est en train de développer une nouvelle formulation topique brevetée de finastéride pour le traitement de la calvitie masculine.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
780995130
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
TOPIRX Therapeutics Inc.
Recipient Postal Code
V6H 4B1
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2019-2020-Q2-933410
